Cargando…

Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis

INTRODUCTION: Although universal drug susceptibility testing (DST) is a component of the End-TB Strategy, over 70% of drug-resistant tuberculosis (DR-TB) cases globally remain undetected. This detection gap reflects difficulties in DST scale-up and substantial heterogeneity in policies and implement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svadzian, Anita, Sulis, Giorgia, Gore, Genevieve, Pai, Madhukar, Denkinger, Claudia M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549483/ https://www.ncbi.nlm.nih.gov/pubmed/33037062 http://dx.doi.org/10.1136/bmjgh-2020-003438

Ejemplares similares

Countries need to step up to end tuberculosis
por: Svadzian, Anita, et al.
Publicado: (2017)

Use of standardised patients to assess tuberculosis case management by private pharmacies in Patna, India: A repeat cross-sectional study
por: Svadzian, Anita, et al.
Publicado: (2023)

Do private providers initiate anti-tuberculosis therapy on the basis of chest radiographs? A standardised patient study in urban India
por: Svadzian, Anita, et al.
Publicado: (2023)

Isoniazid-resistant tuberculosis: A problem we can no longer ignore
por: Sulis, Giorgia, et al.
Publicado: (2020)

Diagnostic Accuracy of Stool Xpert MTB/RIF for Detection of Pulmonary Tuberculosis in Children: a Systematic Review and Meta-analysis
por: MacLean, Emily, et al.
Publicado: (2019)

Tuberculosis case fatality in India: a systematic review and meta-analysis
por: Huddart, Sophie, et al.
Publicado: (2020)

Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis
por: Sulis, Giorgia, et al.
Publicado: (2020)

Time for high-burden countries to lead the tuberculosis research agenda
por: Pai, Madhukar
Publicado: (2018)

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016
por: Cazabon, Danielle, et al.
Publicado: (2018)

Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies
por: Schumacher, Samuel G., et al.
Publicado: (2016)

Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination
por: Raviglione, Mario, et al.
Publicado: (2016)

Global health degrees: at what cost?
por: Svadzian, Anita, et al.
Publicado: (2020)

A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?
por: Bigio, Jacob, et al.
Publicado: (2023)

Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis
por: Sulis, Giorgia, et al.
Publicado: (2021)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
por: Denkinger, Claudia M., et al.
Publicado: (2014)

Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries
por: Pai, Nitika Pant, et al.
Publicado: (2012)

Impact of fluoroquinolone treatment on delay of tuberculosis diagnosis: A systematic review and meta-analysis
por: Hogan, Catherine A, et al.
Publicado: (2016)

Advances in Molecular Diagnosis of Tuberculosis
por: MacLean, Emily, et al.
Publicado: (2020)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers
por: Singhroy, Diane N., et al.
Publicado: (2020)

How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers
por: Faust, Lena, et al.
Publicado: (2020)

Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
por: Daftary, Amrita, et al.
Publicado: (2016)

New tuberculosis estimates must motivate countries to act
por: Pai, Madhukar, et al.
Publicado: (2017)

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults
por: Murray, Matthew, et al.
Publicado: (2016)

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study
por: MacLean, Emily Lai-Ho, et al.
Publicado: (2023)

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
por: Albert, Heidi, et al.
Publicado: (2016)

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya
por: Sulis, Giorgia, et al.
Publicado: (2020)

Engaging pharmacies in tuberculosis control: operational lessons from 19 case detection interventions in high-burden countries
por: Bigio, Jacob, et al.
Publicado: (2022)

Over-the-counter antibiotic dispensing by pharmacies: a standardised patient study in Udupi district, India
por: Nafade, Vaidehi, et al.
Publicado: (2019)

Finding the missing millions: lessons from 10 active case finding interventions in high tuberculosis burden countries
por: Pande, Tripti, et al.
Publicado: (2020)

Most common reasons for primary care visits in low- and middle-income countries: A systematic review
por: Bigio, Jacob, et al.
Publicado: (2022)

Tuberculosis: Epidemiology and Control
por: Sulis, Giorgia, et al.
Publicado: (2014)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018)

Tuberculosis among Health-Care Workers in Low- and Middle-Income Countries: A Systematic Review
por: Joshi, Rajnish, et al.
Publicado: (2006)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests
por: MacLean, Emily L., et al.
Publicado: (2022)

Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review
por: Bigio, Jacob, et al.
Publicado: (2021)

Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges
por: Pai, Madhukar
Publicado: (2015)

Promoting Affordable and Quality Tuberculosis Testing in India
por: Pai, Madhukar
Publicado: (2013)

Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
por: Lange, Christoph, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l896so2tgdjg286n9shngoej2d